New nasal spray aims to shield asthmatics from cold virus attacks
NCT ID NCT07488897
First seen Mar 28, 2026 · Last updated Apr 14, 2026 · Updated 4 times
Summary
This study is testing a new nasal spray called RIG-101 to see if it can help prevent asthma symptoms from getting worse when people catch a common cold. The trial has two parts: first checking the spray's safety in healthy people, then testing if it reduces breathing problems in adults with asthma who are exposed to a cold virus. The goal is to see if this spray can be a new way to manage asthma triggered by respiratory infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY AND EFFICACY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medicines Evaluation Unit
RECRUITINGManchester, M23 9QZ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Virtus Respiratory Research Ltd
NOT_YET_RECRUITINGLondon, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.